Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy

Owing to their professional antigen-presenting capacity and unique potential to induce tumor antigen-specific T cell immunity, dendritic cells (DCs) have attracted much interest over the past decades for therapeutic vaccination against cancer. Clinical trials have shown that the use of tumor antigen...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Anguille, Sébastien, Lion, Eva, Van den Bergh, Johan, Van Acker, Heleen H, Willemen, Yannick, Smits, Evelien L, Van Tendeloo, Viggo F, Berneman, Zwi N
Format: Artigo
Langue:Inglês
Publié: Landes Bioscience 2013
Sujets:
Commentary
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3906362/
https://ncbi.nlm.nih.gov/pubmed/23778748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.25373
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires